Serum YKL-40 isassociated with bone disease in multiple myeloma

被引：0
|
作者：
Mylin, A. K.
Abildgaard, N.
Johansen, J. S.
Andersen, N. F.
Gimsing, P.
Knudsen, L. M.
机构：
[1] Univ Copenhagen, Rigshosp, Dept Haematol, DK-2100 Copenhagen, Denmark
[2] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark
[3] Univ Copenhagen, Herlev Hosp, Dept Rheumatol, DK-2730 Herlev, Denmark
[4] Aarhus Univ Hosp, Dept Haematol, DK-8000 Aarhus, Denmark
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [1] Serum YKL-40 and bone marrow angiogenesis in multiple myeloma
    Mylin, Anne K.
    Andersen, Niels F.
    Johansen, Julia S.
    Abildgaard, Niels
    Heickendorff, Lene
    Standal, Therese
    Gimsing, Peter
    Knudsen, Lene M.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) : 1492 - 1494
  • [2] High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients
    Mylin, Anne K.
    Abildgaard, Niels
    Johansen, Julia S.
    Andersen, Niels F.
    Heickendorff, Lene
    Standal, Therese
    Gimsing, Peter
    Knudsen, Lene M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (04) : 310 - 317
  • [3] Serum YKL-40 correlates with serum interleukin-6 in multiple myeloma
    Mylin, A. K.
    Andersen, N. F.
    Johansen, J. S.
    Abildgaard, N.
    Gimsing, P.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 115 - 115
  • [4] Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells
    Mylin, Anne K.
    Rasmussen, Thomas
    Johansen, Julia S.
    Knudsen, Lene M.
    Norgaard, Peter H.
    Lenhoff, Stig
    Dahl, Inger M. S.
    Johnsen, Hans E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 416 - 424
  • [5] Serum YKL-40 levels in patients with multiple sclerosis
    Donder, Ahmet
    Ozdemir, Hasan Huseyin
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (09) : 795 - 798
  • [6] Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma
    Mylin, Anne K.
    Abildgaard, Niels
    Johansen, Julia S.
    Heickendorff, Lene
    Kreiner, Svend
    Waage, Anders
    Turesson, Ingemar
    Gimsing, Peter
    LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2650 - 2659
  • [7] Serum YKL-40 in patients with inflammatory bowel disease
    Vind, I
    Johansen, JS
    Fischer-Hansen, B
    Price, PA
    Munkholm, P
    GASTROENTEROLOGY, 2001, 120 (05) : A276 - A276
  • [8] Clinical significance of serum YKL-40 in Behcet disease
    Seo, J.
    Ahn, Y.
    Zheng, Z.
    Kim, B. O.
    Choi, M. J.
    Bang, D.
    Kim, D. Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (06) : 1337 - 1344
  • [9] Serum YKL-40 and MDA levels in Behcet disease
    Bilen, Handan
    Altinkaynak, Konca
    Sebin, Engin
    Aksoy, Hulya
    Akcay, Fatih
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2016, 66 (10) : 1299 - 1302
  • [10] Serum YKL-40 and colorectal cancer
    C Cintin
    J S Johansen
    I J Christensen
    P A Price
    S Sørensen
    H J Nielsen
    British Journal of Cancer, 1999, 79 : 1494 - 1499
12345